SIBUTRAMINE Side Effects

6818340-5 | Pulmonary Embolism
on Jul 01, 2010 Female patient from NEW ZEALAND , 60 years of age, was diagnosed with obesity (What is obesity?) and was treated with Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Sibutramine dosage: .

6817792-4 | Meningococcal Sepsis
Patient was taking Sibutramine (View Usage). Patient had the following side effects: meningococcal sepsis on Jul 01, 2010 from NEW ZEALAND Additional patient health information: Male patient , 44 years of age, was diagnosed with obesity (What is obesity?) and. Sibutramine dosage: .

6796177-3 | Pulmonary Embolism
Adverse event was reported on Jun 22, 2010 by a Female patient taking Sibutramine (View Usage) (Dosage: ) was diagnosed with obesity (What is obesity?) and. Location: NEW ZEALAND , 60 years of age, After Sibutramine was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?).

6796176-1 | Meningococcal Sepsis
on Jun 22, 2010 Male patient from NEW ZEALAND , 44 years of age, was diagnosed with obesity (What is obesity?) and was treated with Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: meningococcal sepsis. Sibutramine dosage: .


6786810-4 | Acute Myocardial Infarction, Arteriosclerosis, Hypertension
on Jun 22, 2010 Male patient from NEW ZEALAND , 71 years of age, was diagnosed with obesity (What is obesity?) and was treated with Sibutramine (View Usage). Patient had the following side effects: acute myocardial infarction, arteriosclerosis, hypertension. Sibutramine dosage: .

6786804-9 | Cerebrovascular Accident, Pancreatic Carcinoma Metastatic
Patient was taking Sibutramine (View Usage). After Sibutramine was administered, patient had the following side effects: cerebrovascular accident, pancreatic carcinoma metastatic on Jun 22, 2010 from NEW ZEALAND Additional patient health information: Female patient , 71 years of age, was diagnosed with obesity (What is obesity?) and. Sibutramine dosage: .

6786802-5 | Haemorrhagic Stroke, Hypertension
Adverse event was reported on Jun 22, 2010 by a Male patient taking Sibutramine (View Usage) (Dosage: ) was diagnosed with obesity (What is obesity?) and. Location: NEW ZEALAND , 54 years of age, Patient experienced the following unwanted or unexpected effects: haemorrhagic stroke, hypertension.

6765768-8 | Aphasia, Cerebral Infarction, Condition Aggravated, Diabetes Insipidus, Epilepsy, Headache, Hypotension, Intracranial Pressure Increased, Paralysis
on Jun 03, 2010 Female patient from SWITZERLAND , 40 years of age, weighting 121.3 lb, was treated with Sibutramine (View Usage). Patient had the following side effects: aphasia (What is aphasia?), cerebral infarction, condition aggravated, diabetes insipidus (What is diabetes insipidus?), epilepsy (What is epilepsy?), headache (What is headache?), hypotension, intracranial pressure increased, paralysis (What is paralysis?). Sibutramine dosage: . Patient was hospitalized and became disabled.

6611935-3 | Acute Coronary Syndrome
on Feb 23, 2010 Female patient from SPAIN , 39 years of age, was diagnosed with obesity (What is obesity?), hypertension and was treated with Sibutramine (View Usage). After Sibutramine was administered, patient had the following side effects: acute coronary syndrome. Sibutramine dosage: Not Reported. During the same period patient was treated with CANDESARTAN (Not Reported) (View Candesartan Review and Candesartan Label ).

6474941-8 | Oligohydramnios, Vaginal Haemorrhage
Patient was taking Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: oligohydramnios, vaginal haemorrhage on Nov 24, 2009 from BRAZIL Additional patient health information: Female patient , 30 years of age, was diagnosed with weight decreased, vitamin supplementation and. Sibutramine dosage: . During the same period patient was treated with MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ).

6451304-2 | Cardiac Failure Congestive
Adverse event was reported on Nov 13, 2009 by a Female patient taking Sibutramine (View Usage) (Dosage: ) was diagnosed with obesity (What is obesity?), type 2 diabetes mellitus, hypertension, thrombosis prophylaxis, dyslipidaemia and. Location: SPAIN , weighting 172.4 lb, Patient had the following side effects: cardiac failure congestive. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), INSULINE (View Insuline Review and Insuline Label ), ALTERIDE (View Alteride Review and Alteride Label ), AAS (View Aas Review and Aas Label ), PREVUCOR (View Prevucor Review and Prevucor Label ).

6451218-8 | Brain Neoplasm
on Nov 13, 2009 Female patient from FRANCE , weighting 216.1 lb, was diagnosed with obesity (What is obesity?) and was treated with Sibutramine (View Usage). After Sibutramine was administered, patient had the following side effects: brain neoplasm. Sibutramine dosage: .

6443682-5 | Cardiac Failure Congestive
on Nov 13, 2009 Female patient from SPAIN , weighting 172.4 lb, was diagnosed with obesity (What is obesity?), type 2 diabetes mellitus, hypertension, thrombosis prophylaxis, dyslipidaemia and was treated with Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive. Sibutramine dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), INSULINE (View Insuline Review and Insuline Label ), ALTERIDE (View Alteride Review and Alteride Label ), AAS (View Aas Review and Aas Label ), PREVUCOR (View Prevucor Review and Prevucor Label ).

6443402-4 | Brain Neoplasm
Patient was taking Sibutramine (View Usage). Patient had the following side effects: brain neoplasm on Nov 13, 2009 from FRANCE Additional patient health information: Female patient , weighting 216.1 lb, was diagnosed with obesity (What is obesity?) and. Sibutramine dosage: .

6440457-8 | Porphyria Acute
Adverse event was reported on Nov 05, 2009 by a Female patient taking Sibutramine (View Usage) (Dosage: ) was diagnosed with weight decreased and. Location: GERMANY , 46 years of age, weighting 167.6 lb, After Sibutramine was administered, patient had the following side effects: porphyria acute. Patient was hospitalized.

6384790-7 | Abdominal Discomfort, Constipation, Disturbance In Attention, Erythema, Fatigue, Gastrointestinal Disorder, Gastrointestinal Toxicity, Hunger
on Sep 21, 2009 Female patient from BRAZIL , 35 years of age, weighting 200.6 lb, was diagnosed with weight decreased and was treated with Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, constipation (What is constipation?), disturbance in attention, erythema, fatigue, gastrointestinal disorder, gastrointestinal toxicity, hunger. Sibutramine dosage: 1 Capsule.

6359399-1 | Agitation, Confusional State, Poisoning
on Sep 10, 2009 Female patient from GERMANY , 14 years of age, was treated with Sibutramine (View Usage). Patient had the following side effects: agitation, confusional state, poisoning (What is poisoning?). Sibutramine dosage: . During the same period patient was treated with ATOMOXETINE HCL (View Atomoxetine Hcl Review and Atomoxetine Hcl Label ), METHYLPHENIDATE HCL (View Methylphenidate Hcl Review and Methylphenidate Hcl Label ), CHINESE SLIMMING CAPSULE (View Chinese Slimming Capsule Review and Chinese Slimming Capsule Label ). Patient was hospitalized.

6349461-1 | Disturbance In Attention, Erythema, Fatigue, Hyperhidrosis, Lack Of Satiety, Lymphadenitis, Malaise
Patient was taking Sibutramine (View Usage). After Sibutramine was administered, patient had the following side effects: disturbance in attention, erythema, fatigue, hyperhidrosis, lack of satiety, lymphadenitis, malaise on Sep 01, 2009 from BRAZIL Additional patient health information: Female patient , 35 years of age, weighting 200.6 lb, was diagnosed with weight decreased and. Sibutramine dosage: 1 Capsule.

6347515-7 | Disturbance In Attention, Erythema, Fatigue, Feeling Abnormal, Hyperhidrosis, Ill-defined Disorder, Lymphadenopathy
Adverse event was reported on Sep 01, 2009 by a Female patient taking Sibutramine (View Usage) (Dosage: 1 Capsule) was diagnosed with weight decreased and. Location: BRAZIL , 35 years of age, weighting 200.6 lb, Patient experienced the following unwanted or unexpected effects: disturbance in attention, erythema, fatigue, feeling abnormal, hyperhidrosis, ill-defined disorder, lymphadenopathy.

6341710-9 | Circulatory Collapse, Dyspnoea, Electrocardiogram Qt Prolonged, Hypoxia, Left Ventricular Dysfunction, Respiratory Acidosis, Tachycardia
on Aug 27, 2009 Female patient from AUSTRALIA , weighting 220.5 lb, was treated with Sibutramine (View Usage). Patient had the following side effects: circulatory collapse, dyspnoea, electrocardiogram qt prolonged, hypoxia, left ventricular dysfunction, respiratory acidosis, tachycardia. Sibutramine dosage: . During the same period patient was treated with INDAPAMIDE HEMIHYDRATE (View Indapamide Hemihydrate Review and Indapamide Hemihydrate Label ), QUINAPRIL HYDROCHLORIDE (View Quinapril Hydrochloride Review and Quinapril Hydrochloride Label ).

6232601-2 | Deep Vein Thrombosis, Post Procedural Haematoma
on Jun 11, 2009 Female patient from UNITED KINGDOM , 47 years of age, weighting 176.4 lb, was diagnosed with obesity (What is obesity?) and was treated with Sibutramine (View Usage). After Sibutramine was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), post procedural haematoma. Sibutramine dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), LOSARTAN AND HYDROCHLOROTHIAZIDE (View Losartan And Hydrochlorothiazide Review and Losartan And Hydrochlorothiazide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LEVEMIR (View Levemir Review and Levemir Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ). Patient was hospitalized.

6221285-5 | Deep Vein Thrombosis, Post Procedural Haematoma
Patient was taking Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), post procedural haematoma on Jun 03, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 47 years of age, weighting 176.4 lb, was diagnosed with obesity (What is obesity?) and. Sibutramine dosage: . During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), LOSARTAN AND HYDROCHLOROTHIAZIDE (View Losartan And Hydrochlorothiazide Review and Losartan And Hydrochlorothiazide Label ), METFORMIN (View Metformin Review and Metformin Label ), LEVEMIR (View Levemir Review and Levemir Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ). Patient was hospitalized.

6173955-5 | Cyst, Dry Eye
Adverse event was reported on Apr 22, 2009 by a Female patient taking Sibutramine (View Usage) (Dosage: ) was diagnosed with weight control (What is weight control?), vitamin supplementation and. Location: BRAZIL , weighting 145.5 lb, Patient had the following side effects: cyst, dry eye. During the same period patient was treated with CENTRUM (1/2 Tablet Daily) (View Centrum Review and Centrum Label ).

6121670-6 | Cyst, Dry Eye
on Mar 11, 2009 Female patient from BRAZIL , weighting 145.5 lb, was diagnosed with weight control (What is weight control?), vitamin supplementation and was treated with Sibutramine (View Usage). After Sibutramine was administered, patient had the following side effects: cyst, dry eye. Sibutramine dosage: . During the same period patient was treated with CENTRUM (1/2 Tablet Daily) (View Centrum Review and Centrum Label ).

6094316-3 | Atrial Flutter, Dyspnoea, Palpitations
on Feb 19, 2009 Female patient from UNITED KINGDOM , 49 years of age, weighting 220.5 lb, was diagnosed with obesity (What is obesity?) and was treated with Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: atrial flutter, dyspnoea, palpitations. Sibutramine dosage: .

6082262-0 | Cardiac Arrest, Electrocardiogram Qt Prolonged
Patient was taking Sibutramine (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged on Feb 10, 2009 from AUSTRALIA Additional patient health information: Female patient , 51 years of age, was diagnosed with obesity (What is obesity?) and. Sibutramine dosage: . Patient was hospitalized.

6057621-2 | Hypomania
Adverse event was reported on Jan 22, 2009 by a Female patient taking Sibutramine (View Usage) (Dosage: ) was diagnosed with overweight, bipolar i disorder and. Location: BRAZIL , 27 years of age, After Sibutramine was administered, patient had the following side effects: hypomania. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ). Patient was hospitalized.

6014762-3 | Cardiac Failure, Mitral Valve Incompetence
on Dec 09, 2008 Male patient from BELGIUM , weighting 206.6 lb, was diagnosed with obesity (What is obesity?), myocardial ischaemia, sleep disorder (What is sleep disorder?), depression (What is depression?) and was treated with Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, mitral valve incompetence. Sibutramine dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOXAZOLAM (View Cloxazolam Review and Cloxazolam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), DEANXIT (View Deanxit Review and Deanxit Label ). Patient was hospitalized.

5979405-3 | Psychotic Disorder
on Nov 26, 2008 Male patient from TURKEY , 15 years of age, was diagnosed with weight increased, hypersomnia-bulimia syndrome and was treated with Sibutramine (View Usage). Patient had the following side effects: psychotic disorder (What is psychotic disorder?). Sibutramine dosage: Not Reported. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ). Patient was hospitalized.

5957805-5 | Pulmonary Embolism
Patient was taking Sibutramine (View Usage). After Sibutramine was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?) on Nov 10, 2008 from FRANCE Additional patient health information: Female patient , 32 years of age, was diagnosed with weight control (What is weight control?) and. Sibutramine dosage: . During the same period patient was treated with PHENOLPHTHALEIN (View Phenolphthalein Review and Phenolphthalein Label ), PLANT DERIVED SUBSTANCES WITH LAXATIVE PROPERTIES (View Plant Derived Substances With Laxative Properties Review and Plant Derived Substances With Laxative Properties Label ).

5952561-9 | Hydronephrosis, Retroperitoneal Fibrosis
Adverse event was reported on Nov 04, 2008 by a Female patient taking Sibutramine (View Usage) (Dosage: ) was diagnosed with obesity (What is obesity?), pain (What is pain?), myocardial ischaemia, gastric ulcer, hypercholesterolaemia, thrombosis prophylaxis and. Location: BELGIUM , weighting 172.0 lb, Patient experienced the following unwanted or unexpected effects: hydronephrosis, retroperitoneal fibrosis. During the same period patient was treated with HYOSCINE (View Hyoscine Review and Hyoscine Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5945667-1 | Chorioretinitis, Conjunctival Haemorrhage, Hypertension
on Oct 29, 2008 Female patient from SPAIN , 46 years of age, was diagnosed with obesity (What is obesity?) and was treated with Sibutramine (View Usage). Patient had the following side effects: chorioretinitis, conjunctival haemorrhage, hypertension. Sibutramine dosage: 10 Mg Daily.

5943040-3 | Chorioretinitis, Conjunctival Haemorrhage, Hypertension
on Oct 29, 2008 Female patient from SPAIN , 46 years of age, was diagnosed with obesity (What is obesity?) and was treated with Sibutramine (View Usage). After Sibutramine was administered, patient had the following side effects: chorioretinitis, conjunctival haemorrhage, hypertension. Sibutramine dosage: 10 Mg Daily.

5909453-0 | Cardiac Failure, Mitral Valve Incompetence
Patient was taking Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, mitral valve incompetence on Sep 26, 2008 from BELGIUM Additional patient health information: Male patient , weighting 206.6 lb, was diagnosed with obesity (What is obesity?), myocardial ischaemia, sleep disorder (What is sleep disorder?), depression (What is depression?) and. Sibutramine dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CLOXAZOLAM (View Cloxazolam Review and Cloxazolam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), DEANXIT (View Deanxit Review and Deanxit Label ). Patient was hospitalized.

5892140-5 | Cardiac Arrest, Electrocardiogram Qt Prolonged
Adverse event was reported on Sep 15, 2008 by a Female patient taking Sibutramine (View Usage) (Dosage: ) was diagnosed with obesity (What is obesity?) and. Location: AUSTRALIA , 51 years of age, Patient had the following side effects: cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged. Patient was hospitalized.

5880224-7 | Gliosis, Irritability, Mania, Poverty Of Thought Content, Psychotic Disorder, Sleep Disorder, Weight Increased
on Sep 05, 2008 Female patient from CHILE , 42 years of age, was diagnosed with obesity (What is obesity?) and was treated with Sibutramine (View Usage). After Sibutramine was administered, patient had the following side effects: gliosis, irritability, mania, poverty of thought content, psychotic disorder (What is psychotic disorder?), sleep disorder (What is sleep disorder?), weight increased. Sibutramine dosage: . During the same period patient was treated with SERTRALINE (View Sertraline Review and Sertraline Label ), CHLORDIAZEPOXIDE HCL (View Chlordiazepoxide Hcl Review and Chlordiazepoxide Hcl Label ). Patient was hospitalized.

5879515-5 | Activated Partial Thromboplastin Time Prolonged, Anxiety, Back Pain, Cardiac Failure, Cardiomegaly, Condition Aggravated, Depression, Dizziness, Gastric Ulcer
on Sep 02, 2008 Male patient from BELGIUM , weighting 206.6 lb, was diagnosed with obesity (What is obesity?), myocardial ischaemia, sleep disorder (What is sleep disorder?), depression (What is depression?) and was treated with Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, anxiety (What is anxiety?), back pain (What is back pain?), cardiac failure, cardiomegaly, condition aggravated, depression (What is depression?), dizziness (What is dizziness?), gastric ulcer. Sibutramine dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CLOXAZOLAM (View Cloxazolam Review and Cloxazolam Label ), TRAZODONE HYDROCHLORIDE (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ), DEANXIT (View Deanxit Review and Deanxit Label ). Patient was hospitalized.

5868114-7 | Mania, Psychotic Disorder
Patient was taking Sibutramine (View Usage). Patient had the following side effects: mania, psychotic disorder (What is psychotic disorder?) on Aug 25, 2008 from CHILE Additional patient health information: Female patient , 42 years of age, was diagnosed with obesity (What is obesity?) and. Sibutramine dosage: . During the same period patient was treated with SERTRALINE (View Sertraline Review and Sertraline Label ), CHLORDIAZEPOXIDE HCL (View Chlordiazepoxide Hcl Review and Chlordiazepoxide Hcl Label ). Patient was hospitalized.

5849935-3 | Acute Myocardial Infarction
Adverse event was reported on Aug 11, 2008 by a Male patient taking Sibutramine (View Usage) (Dosage: Not Reported) . Location: TURKEY , 24 years of age, After Sibutramine was administered, patient had the following side effects: acute myocardial infarction.

5849798-6 | Dizziness, Feeling Drunk, Mood Swings, Paraesthesia, Visual Impairment
on Aug 12, 2008 Female patient from UNITED KINGDOM , 47 years of age, weighting 297.6 lb, was diagnosed with obesity (What is obesity?), diabetes mellitus and was treated with Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), feeling drunk, mood swings, paraesthesia, visual impairment. Sibutramine dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), INSULIN ASPART (Approximately 20-30 Iu-4 Times A Day) (View Insulin Aspart Review and Insulin Aspart Label ), LANTUS (View Lantus Review and Lantus Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

5841965-0 | Amenorrhoea, Blood Follicle Stimulating Hormone Increased, Hot Flush, Hyperhidrosis, Infertility
on Aug 05, 2008 Female patient from UNITED KINGDOM , 44 years of age, weighting 302.5 lb, was diagnosed with obesity (What is obesity?) and was treated with Sibutramine (View Usage). Patient had the following side effects: amenorrhoea, blood follicle stimulating hormone increased, hot flush, hyperhidrosis, infertility (What is infertility?). Sibutramine dosage: . During the same period patient was treated with ACETAMINOPHEN W/ CODEINE (View Acetaminophen W/ Codeine Review and Acetaminophen W/ Codeine Label ).

5813415-1 | Inappropriate Antidiuretic Hormone Secretion
Patient was taking Sibutramine (View Usage). After Sibutramine was administered, patient had the following side effects: inappropriate antidiuretic hormone secretion on Jul 09, 2008 from ITALY Additional patient health information: Female patient , 51 years of age, was diagnosed with obesity (What is obesity?) and. Sibutramine dosage: . Patient was hospitalized.

5759945-2 | Psychiatric Evaluation
Adverse event was reported on May 28, 2008 by a Female patient taking Sibutramine (View Usage) (Dosage: ) was diagnosed with weight control (What is weight control?) and. Location: AUSTRALIA , 23 years of age, Patient experienced the following unwanted or unexpected effects: psychiatric evaluation. Patient was hospitalized.

5751016-4 | Acute Myeloid Leukaemia
on May 21, 2008 Male patient from UNITED KINGDOM , weighting 374.8 lb, was diagnosed with obesity (What is obesity?), diabetes mellitus, blood pressure increased and was treated with Sibutramine (View Usage). Patient had the following side effects: acute myeloid leukaemia. Sibutramine dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5699537-7 | Vaginal Haemorrhage
on Apr 02, 2008 Female patient from UNITED KINGDOM , 22 years of age, weighting 164.2 lb, was diagnosed with obesity (What is obesity?), contraception and was treated with Sibutramine (View Usage). After Sibutramine was administered, patient had the following side effects: vaginal haemorrhage. Sibutramine dosage: . During the same period patient was treated with EUGYNON (View Eugynon Review and Eugynon Label ).

5695290-1 | Anorexia, Demyelination, Depression, Dysphonia, Dyspnoea, Fatigue, Gait Disturbance, Haematemesis, Herpes Simplex
Patient was taking Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, demyelination, depression (What is depression?), dysphonia, dyspnoea, fatigue, gait disturbance, haematemesis, herpes simplex (What is herpes simplex?) on Mar 26, 2008 from BRAZIL Additional patient health information: Female patient , 57 years of age, was diagnosed with weight decreased, obesity (What is obesity?), hypothyroidism, hysterectomy (What is hysterectomy?) and. Sibutramine dosage: . During the same period patient was treated with AMFEPRAMONE HYDROCHLORIDE (View Amfepramone Hydrochloride Review and Amfepramone Hydrochloride Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ). Patient was hospitalized.

5689178-X | Cerebral Disorder, Demyelination, Dysphonia, Muscle Contracture, Nervous System Disorder, Quadriplegia
Adverse event was reported on Mar 24, 2008 by a Female patient taking Sibutramine (View Usage) (Dosage: ) was diagnosed with weight control (What is weight control?) and. Location: BRAZIL , 57 years of age, Patient had the following side effects: cerebral disorder, demyelination, dysphonia, muscle contracture, nervous system disorder, quadriplegia. Patient was hospitalized.

5668695-2 | Overdose, Poisoning
on Mar 06, 2008 Female patient from BRAZIL , 27 years of age, weighting 136.7 lb, was diagnosed with ex-smoker and was treated with Sibutramine (View Usage). After Sibutramine was administered, patient had the following side effects: overdose, poisoning (What is poisoning?). Sibutramine dosage: . During the same period patient was treated with DIETHYLPROPION HCL (View Diethylpropion Hcl Review and Diethylpropion Hcl Label ), BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ).

5661191-8 | Catatonia, Psychotic Disorder
on Mar 03, 2008 Female patient from UNITED STATES , 26 years of age, weighting 88.18 lb, was diagnosed with weight control (What is weight control?) and was treated with Sibutramine (View Usage). Patient experienced the following unwanted or unexpected effects: catatonia, psychotic disorder (What is psychotic disorder?). Sibutramine dosage: . Patient was hospitalized.

5649620-7 | Overdose, Poisoning
Patient was taking Sibutramine (View Usage). Patient had the following side effects: overdose, poisoning (What is poisoning?) on Feb 25, 2008 from BRAZIL Additional patient health information: Female patient , 27 years of age, weighting 136.7 lb, . Sibutramine dosage: . During the same period patient was treated with DIETHYLPROPION HCL (View Diethylpropion Hcl Review and Diethylpropion Hcl Label ).